SER Familia for Stress and Resilience in Latino Families
(SER Familia Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a family-based program called SER Familia, designed to help Latino families manage stress and enhance resilience. Community health workers lead six sessions to reduce stress from cultural adaptation and improve family health and social connections. The trial examines how effectively this approach can prevent issues such as substance abuse, depression, and anxiety. Families who identify as Hispanic/Latino, are first-generation immigrants, have children aged 12-17, and speak English or Spanish may be suitable participants. As an unphased trial, this study offers families the chance to contribute to research that could improve community health and resilience.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the SER Familia intervention is safe?
A previous study showed that SER Familia helped participants feel safer and more connected to their communities. Family support and community health workers lead this program. No reports of serious side effects exist, as it focuses on improving family relationships and reducing stress. Since this is a behavioral program without medication, the risk of physical side effects remains very low. Participants generally report positive experiences, indicating that SER Familia is well-tolerated and safe.12345
Why are researchers excited about this trial?
Researchers are excited about the SER Familia intervention because it offers a culturally tailored approach to managing stress and building resilience in Latino families. Unlike standard interventions that might not address specific cultural nuances, SER Familia focuses on health (Salud), stress (Estrés), and resilience (Resilencia) in a way that resonates with Latino cultural values and experiences. This personalized approach aims to foster stronger family connections and coping mechanisms, potentially leading to more effective and sustainable outcomes in stress management and resilience building.
What evidence suggests that SER Familia is effective for reducing acculturative stress and promoting resilience?
Research has shown that SER Familia, which participants in this trial may receive, can help reduce stress from adapting to a new culture and increase resilience in Latino families. This type of stress, known as acculturative stress, can lead to health problems like substance abuse and depression. In past programs, all participants reported feeling safer and more connected to their communities after completing the program. This family-focused approach also aims to improve family relationships and help members make better use of community resources. Early results suggest that by strengthening family and community connections, SER Familia can help lower the risk of mental health and behavioral issues.12367
Are You a Good Fit for This Trial?
This trial is for first-generation immigrant Hispanic/Latino/a/x/e parents with a child aged 12-17. It aims to help families reduce stress related to adapting to a new culture and strengthen their resilience, which may improve overall health and prevent issues like substance abuse, domestic violence, HIV risk, depression, and anxiety.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the SER Familia intervention, consisting of six sessions delivered by community health workers to reduce acculturative stress and promote resilience
Follow-up
Participants are monitored for changes in acculturative stress, resilience, and overall health
Long-term Follow-up
Participants' perceptions of the impact of SER Familia are assessed through semi-structured interviews
What Are the Treatments Tested in This Trial?
Interventions
- SER Familia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator